Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Gabriel Heering"'
Publikováno v:
Case Reports in Gastroenterology, Vol 18, Iss 1, Pp 273-278 (2024)
Introduction: AL amyloidosis can involve the gastrointestinal (GI) tract in a sporadic manner, affecting certain anatomical areas while sparing others. Case Presentation: Our patient with AL amyloidosis and confirmed colonic involvement was found to
Externí odkaz:
https://doaj.org/article/ca8ac5dba423482f89cc564b491118c8
Autor:
Gal Sharvit, Daniel Schwartz, Gabriel Heering, Alexander Shulman, Abraham Avigdor, Galia Rahav, Amos Toren, Arnon Nagler, Jonathan Canaani
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The clinical yield and benefit of performing bone marrow cultures for various clinical indications has been challenged and their clinical necessity remains debatable. We sought to assess the clinical yield and benefit of performing routine b
Externí odkaz:
https://doaj.org/article/a69132e642354dafa5896661b6c39ff8
Autor:
Naama Keren-Froim, Gabriel Heering, Gal Sharvit, Maya Zlotnik, Arnon Nagler, Avichai Shimoni, Abraham Avigdor, Jonathan Canaani
Publikováno v:
Annals of Hematology. 101:309-316
Early mortality remains a challenging therapeutic facet of the initial induction phase of intensive chemotherapy in patients with acute myeloid leukemia (AML). The impact of standard molecular evaluation and risk category of the European LeukemiaNet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4146924c1d777147e5c6f06adaedc8
https://doi.org/10.1007/s00277-021-04716-4
https://doi.org/10.1007/s00277-021-04716-4
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 years
Autor:
Gabriel Heering, Maya Sasson, Dan Dominissini, Avichai Shimoni, Abraham Avigdor, Arnon Nagler, Jonathan Canaani
Publikováno v:
European journal of haematologyREFERENCES. 109(6)
Define clinical and laboratory attributes of acute myeloid leukemia (AML) patients with long-term survival exceeding five years and compare them with AML patients succumbing to disease within 2 years of diagnosis.A retrospective analysis of AML patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c699d3fbcace6e4752bbbb0523fb6706
https://pubmed.ncbi.nlm.nih.gov/36128925
https://pubmed.ncbi.nlm.nih.gov/36128925
Autor:
G. Rechavi, Drorit Merkel, Avichai Shimoni, Chen Gefen, Jonathan Canaani, Yulia Volchek, Noga Shem-Tov, Arnon Nagler, Meital Nagar, Ronit Yerushalmi, Abraham Avigdor, Gabriel Heering, Ninette Amariglio
Publikováno v:
Oncotarget
A substantial segment of patients with acute myeloid leukemia (AML) will relapse following an initial response to induction therapy or will prove to be primary refractory. High-dose cytarabine and mitoxantrone (HiDAC/MITO) is an established salvage t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a29f53291d5d8306d781e9b4d88bc6e
https://doi.org/10.18632/oncotarget.27618
https://doi.org/10.18632/oncotarget.27618
Publikováno v:
American Journal of Gastroenterology. 117:e1757-e1757
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dcb1b09ba00f0bc92b09731e44d95be
https://doi.org/10.14309/01.ajg.0000867276.45886.9c
https://doi.org/10.14309/01.ajg.0000867276.45886.9c
Autor:
Danielle Fredman, Yakir Moshe, Ofir Wolach, Gabriel Heering, Keren Shichrur, Idan Goldberg, Liron Hofstetter, Miriam Neaman, Tomer Scheib, Victoria Marcu-Malina, Abraham Avigdor, Avichai Shimoni, Arnon Nagler, Jonathan Canaani
Publikováno v:
Annals of hematology. 101(3)
Chemotherapy-based approaches still constitute an essential feature in the treatment paradigm of adult acute lymphoblastic leukemia (ALL). The German Multicenter Study Group (GMALL) is a well-established protocol for ALL. In this study, we assessed o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::909b433d6c132397f0b2eb774e459ff9
https://pubmed.ncbi.nlm.nih.gov/35088172
https://pubmed.ncbi.nlm.nih.gov/35088172
Autor:
Arnon Nagler, Jonathan Canaani, Gal Sharvit, Abraham Avigdor, Gabriel Heering, Maya Zlotnik, Avichai Shimoni, Drorit Merkel
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(2)
Achievement of initial remission remains the most important clinical factor predicting long term survival in acute myeloid leukemia (AML) patients treated with intensive chemotherapy. Yet, whether the patient subset in need of a second cycle of inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422c25ef2d4e99e964d985e964201113
https://pubmed.ncbi.nlm.nih.gov/34593360
https://pubmed.ncbi.nlm.nih.gov/34593360
Autor:
Avichai Shimoni, Jonathan Canaani, Arnon Nagler, Abraham Avigdor, Naama Keren Froim, Gal Sharvit, Maya Zlotnick, Gabriel Heering
Publikováno v:
Blood. 138:3392-3392
Background. Early mortality remains a challenging therapeutic facet of the initial induction phase of intensive chemotherapy in patients with acute myeloid leukemia (AML). The impact of standard molecular evaluation and risk category of the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22cd2651e26fc0eece0edfd8a6b61281
https://doi.org/10.1182/blood-2021-145551
https://doi.org/10.1182/blood-2021-145551
Autor:
Gal Sharvit, Gabriel Heering, Maya Zlotnick, Arnon Nagler, Abraham Avigdor, Avichai Shimoni, Jonathan Canaani
Publikováno v:
Blood. 138:3390-3390
Background: Achievement of initial remission remains the most important clinical factor predicting long term survival in acute myeloid leukemia (AML) patients treated with intensive chemotherapy. Yet, whether the patient subset in need of a second cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9160fe5a30e1739303a32e461ef58500
https://doi.org/10.1182/blood-2021-145552
https://doi.org/10.1182/blood-2021-145552